NovoCure Ltd. (NVCR)
17.89
+1.06
(+6.30%)
USD |
NASDAQ |
May 08, 16:00
17.96
+0.07
(+0.39%)
After-Hours: 20:00
NovoCure Cash from Investing (Quarterly) : 7.747M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| LivaNova Plc | -14.58M |
| AtriCure, Inc. | -3.852M |
| LeMaitre Vascular, Inc. | -13.12M |
| Globus Medical, Inc. | -182.67M |
| Glaukos Corp. | 10.50M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -13.52M |
| Cash from Financing (Quarterly) | -0.166M |
| Free Cash Flow | -48.07M |
| Free Cash Flow Per Share (Quarterly) | -0.1635 |
| Free Cash Flow to Equity (Quarterly) | -5.256M |
| Free Cash Flow to Firm (Quarterly) | -16.78M |
| Free Cash Flow Yield | -2.39% |